Eyenovia Inc. (EYEN) is a clinical stage company specializing in developing innovative, advanced eye therapies. With a focus on improving the delivery of ophthalmic medications, Eyenovia aims to provide patients with convenient, cost-effective, and precise treatments. Through its novel microdosing platform, the company has the potential to revolutionize the way eye conditions are treated.